NIAID Sees Notable Increase in Data Access, Storage through Clinical Genomics Program

The agency is improving the way clinical data is linked to patients and making genome sequencing data more available to researchers.
The National Institute of Allergy and Infectious Diseases (NIAID), the national agency dedicated to better understanding and treating disorders of the immune system, requires fast and easy access to data for things like clinical trials and genomic sequencing that are critical to developing new vaccines and treatments. Its Clinical Genomics Program is one way opened up a world of data to researchers. NIAID CIO Mike Tartakovsky highlighted several of the new technologies he has implemented to better share and protect clinical data and touted the agency’s new Biovisualization Lab that is applying virtual reality technology in biomedical research.

-
Mike Tartakovsky CIO NIAID
-
AFCEA West: AI is America’s ‘Sputnik Moment,’ Defense Academic Says
NPS president says that ‘warrior scholars’ bridge research and implementable capabilities for national security.
12m listen -
Defending the Cyber Domain in a Time of 'Non-Kinetic' Threats
Northcom's intelligence leader Brig. Gen. Maurizio Calabrese discussed the evolving role of defense intelligence technology.
20m watch -
The Year Ahead: FBI’s 2025 Cybersecurity Priorities
The FBI is increasing awareness of vulnerabilities and employing AI-enabled tools to secure networks from sophisticated cyber threats.
25m listen -
OPM Navigates AI Governance Through People
OPM's Taka Ariga explores AI's role in an efficient federal workforce and operations, focusing on trust, data integrity and storytelling.
19m listen